HIV-1 REVERSE-TRANSCRIPTASE RESIDUES THAT INFLUENCE SENSITIVITY TO NONNUCLEOSIDE INHIBITORS

被引：0

作者：

BYRNES, VW ^{[1
]}

SARDANA, VV ^{[1
]}

CONDRA, JH ^{[1
]}

SCHLEIF, WA ^{[1
]}

SCHNEIDER, CL ^{[1
]}

WATERBURY, JA ^{[1
]}

WOLFGANG, JA ^{[1
]}

GRAHAM, DJ ^{[1
]}

GOTLIB, L ^{[1
]}

SCHLABACH, AJ ^{[1
]}

WOLANSKI, BS ^{[1
]}

LONG, WJ ^{[1
]}

RHODES, A ^{[1
]}

TITUS, DL ^{[1
]}

ROTH, E ^{[1
]}

BLAHY, OM ^{[1
]}

EMINI, EA ^{[1
]}

机构：

[1] MERCK RES LABS,W POINT,PA 19486

来源：

JOURNAL OF CELLULAR BIOCHEMISTRY | 1993年

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：75 / 75

页数：1

共 50 条

[41] New Pyridinone Derivatives as Potent HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors
Le Van, Kiet
Cauvin, Christine
de Walque, Stephane
Georges, Benoit
Boland, Sandro
Martinelli, Valerie
Demonte, Dominique
Durant, Francois
Hevesi, Laszlo
Van Lint, Carine
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (12) : 3636 - 3643
[42] Mechanisms of HIV-1 drug resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
Nikolenko, G. N.
Kotelkin, A. T.
Oreshkova, S. F.
Ilyichev, A. A.
MOLECULAR BIOLOGY, 2011, 45 (01) : 93 - 109
[43] RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TO NONNUCLEOSIDE HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS
DECLERCQ, E
INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1994, 10 (04): : 145 - 158
[44] FUNCTIONAL-ANALYSIS OF HIV-1 REVERSE-TRANSCRIPTASE AMINO-ACIDS INVOLVED IN RESISTANCE TO MULTIPLE NONNUCLEOSIDE INHIBITORS
SARDANA, VV
EMINI, EA
GOTLIB, L
GRAHAM, DJ
LINEBERGER, DW
LONG, WJ
SCHLABACH, AJ
WOLFGANG, JA
CONDRA, JH
JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (25) : 17526 - 17530
[45] DISCOVERY, SYNTHESIS, AND BIOACTIVITY OF BIS(HETEROARYL)PIPERAZINES .1. A NOVEL CLASS OF NONNUCLEOSIDE HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS
ROMERO, DL
MORGE, RA
BILES, C
BERRIOSPENA, TN
MAY, PD
PALMER, JR
JOHNSON, PD
SMITH, HW
BUSSO, M
TAN, CK
VOORMAN, RL
REUSSER, F
ALTHAUS, IW
DOWNEY, KM
SO, AG
RESNICK, L
TARPLEY, WG
ARISTOFF, PA
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (07) : 999 - 1014
[46] Nonnucleoside inhibitors of HIV-1 reverse transcriptase: From the biology of reverse transcription to molecular design
Tronchet, JMJ
Seman, M
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (13) : 1496 - 1511
[47] EFFECT OF TEMPLATE SECONDARY STRUCTURE ON THE INHIBITION OF HIV-1 REVERSE-TRANSCRIPTASE BY A PYRIDINONE NONNUCLEOSIDE INHIBITOR
OLSEN, DB
CARROLL, SS
CULBERSON, JC
SHAFER, JA
KUO, LC
NUCLEIC ACIDS RESEARCH, 1994, 22 (08) : 1437 - 1443
[48] A RAPID BIOASSAY FOR THE DETERMINATION OF NONNUCLEOSIDE HIV-1 REVERSE-TRANSCRIPTASE INHIBITOR PLASMA-LEVELS
OBRIEN, JA
OSTOVIC, D
SCHORN, TW
SMITH, SJ
RUFFING, TL
SIEGL, PKS
GOLDMAN, ME
LIFE SCIENCES, 1993, 52 (03) : 243 - 249
[49] SYNTHESIS OF IMIDAZOBENZAZEPINTHIONES - A NEW SERIES OF HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS
SALASKI, EJ
TETRAHEDRON LETTERS, 1995, 36 (09) : 1387 - 1390
[50] TEMPLATE - PHOSPHOROTHIOATE OLIGONUCLEOTIDES DUPLEXES AS INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE
MAURY, G
ELALAOUI, A
MORVAN, F
MULLER, B
IMBACH, JL
GOODY, RS
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (03) : 1249 - 1256

← 1 2 3 4 5 →